In this exclusive interview, Dr. Gisele Sampaio Silva shares valuable insights on Factor XI inhibitors and their potential to transform stroke prevention. Interview conducted by Prof. Octavio Pontes Neto, Editor-in-Chief of the World Stroke Academy. This activity is supported by an unrestricted educational grant by Bayer AG. #WSC2025 #StrokePrevention #FactorXI #MeetTheTrialist #WSCtvStudio
In this exclusive interview, Dr. Ashkan Shoamanesh shares valuable insights on Factor XI inhibitors and their potential to transform stroke prevention. Interview conducted by Prof. Octavio Pontes Neto, Editor-in-Chief of the World Stroke Academy. This activity is supported by an unrestricted educational grant by Bayer AG. #WSC2025 #StrokePrevention #FactorXI #MeetTheTrialist #WSCtvStudio
In this exclusive interview, Dr. Mike Sharma shares valuable insights on Factor XI inhibitors and their potential to transform stroke prevention. Interview conducted by Prof. Octavio Pontes Neto, Editor-in-Chief of the World Stroke Academy. This activity is supported by an unrestricted educational grant by Bayer AG. #WSC2025 #StrokePrevention #FactorXI #MeetTheTrialist #WSCtvStudio
How can stroke care be improved globally through real-time data? In this episode, Prof. Robert Mikulik speaks with Prof. Octavio Marques Pontes-Neto about the RES-Q Registry of Stroke Care Quality+, a global initiative to support quality improvement in stroke care by collecting and analyzing performance data. Learn how real-time data collection and benchmarking are helping stroke centers worldwide enhance outcomes and performance. Learn more here: https://stroke.qualityregistry.org/
In this insightful interview, Prof. Octavio Pontes Neto speaks with Prof. Craig Anderson about the latest pooled analysis on intracerebral hemorrhage (ICH), offering compelling evidence that early and intensive blood pressure (BP) lowering significantly improves outcomes. They discuss key findings, the implications for acute ICH management, and how this evidence supports the urgency of BP control in the hyperacute phase. A must-watch for clinicians and researchers involved in stroke care and emergency medicine.
Join Prof. Octavio Pontes and Prof. Raul Nogueira as they delve into the latest advancements in stroke care, focusing on mechanical thrombectomy. In this insightful episode, Prof. Nogueira discusses the BRIDGE-TNK trial, collaboratively led by experts from Chongqing, China, which investigates the efficacy of Tenecteplase (TNK) as a pre-thrombectomy treatment. Listeners will gain an understanding of the rationale behind using TNK over Alteplase, highlighting significant findings from major clinical trials, including insights from the EXTEND-IA-TNK trial. Discover the potential benefits and risks of thrombolytic agents for patients with proximal artery occlusion and how these studies influence current medical practices, as well as ongoing trials, such as the Resilient Direct TNK trial in Brazil, and the importance of diverse demographic participation in research.